Kisqali and Indapamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kisqali (ribociclib succinate) and Indapamide (indapamide). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Kisqali and Indapamide. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Kisqali?

Kisqali has active ingredients of ribociclib succinate. eHealthMe is studying from 25,049 Kisqali users. Check the latest studies of Kisqali.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

On Jul, 19, 2026

27 people who take Kisqali and Indapamide together, and have interactions are studied.

Kisqali and Indapamide drug interactions.

What are the common drug interactions of Kisqali and Indapamide, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Pain
Cough
Dizziness
Eating disorder
Hypersensitivity
Oropharyngeal pain
Skin discolouration (change of skin colour)
Tendonitis (a condition that causes pain and swelling of tendons)
Furuncle (infection of the hair follicle)

male:

n/a

What are the common drug interactions of Kisqali and Indapamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood glucose fluctuation
Blood glucose increased
Breast cancer
Drug ineffective
Malignant neoplasm progression (cancer tumour came back)
Metastases to central nervous system (cancer spreads to central nervous system)
Pelvic pain
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

50-59:

Acne (skin problems that cause pimples)
Aphthous ulcer (mouth ulcer)
Arthralgia (joint pain)
Axillary pain
Bone pain
Chest pain
Cyst (a closed sac)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Diarrhoea
Dizziness

60+:

Decreased immune responsiveness
Pain in extremity
White blood cell count decreased
Electrocardiogram qt prolonged
Abdominal discomfort
Abdominal pain upper
Anxiety
Asthenia (weakness)
Cardiac failure
Chills (felling of cold)

What are the existing conditions these people have? *

Breast Cancer: 18 people, 66.67%
Breast Cancer Metastatic: 15 people, 55.56%
Diabetes: 6 people, 22.22%
High Blood Cholesterol: 4 people, 14.81%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 11.11%
Urination - Excessive Volume: 2 people, 7.41%
Type 2 Diabetes: 2 people, 7.41%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 7.41%
Metastases To Lung (cancer spreads to lung): 2 people, 7.41%
Decreased Immune Responsiveness: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Kisqali and Indapamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously